http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
BD Appoints Shana Neal as Chief People Officer
-
embecta to Host Virtual Investor Event Ahead of Planned Spinoff from BD
-
BD Collaborates with ReturnSafe to Help Employers Manage COVID-19 Testing
-
BD REPORTS FIRST QUARTER FISCAL 2022 FINANCIAL RESULTS
-
Becton Dickinson (BDX) Board of Directors Approves embecta Spinoff and Declares Distribution of embecta Stock
-
BD Board of Directors Approves embecta Spinoff and Declares Distribution of embecta Stock
-
Becton Dickinson (BDX) Announces Acquisition of Cytognos from Vitro S.A.
-
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.
-
BD Recognized for Equality by Bloomberg, Human Rights Campaign
-
New Study Finds Up to One-Third of Women Receive Clinical Misdiagnosis of Vaginitis
-
BD Board Declares Dividend
-
BD (BDX) Innovation Profiled in Cover Story of 'Science' Demonstrates Landmark Advancement in Flow Cytometry Technology
-
BD Innovation Profiled in Cover Story of 'Science' Demonstrates Landmark Advancement in Flow Cytometry Technology
-
BD Named One of America's Most Just Companies in Annual JUST 100 Ranking
-
Becton Dickinson (BDX), Pfizer (PFE) and Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices
-
BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices
-
Becton Dickinson (BDX) Granted FDA 510(k) Clearance for BD Kiestra IdentifA
-
BD Introduces Smart Connected Robotics to Automate Microbial Identification
-
BD Announces Change to Virtual 2022 Annual Meeting of Shareholders
-
BD Publishes 2021 Cybersecurity Annual Report
-
BD TO ANNOUNCE FINANCIAL RESULTS FOR ITS FIRST QUARTER OF FISCAL YEAR 2022
-
BD to Present at the 40th Annual J.P. Morgan Healthcare Conference
-
Becton Dickinson (BDX) Announces New Distribution and Retail Partners for BD Veritor At-Home COVID-19 Test
-
BD Announces New Distribution and Retail Partners for BD Veritorâ„¢ At-Home COVID-19 Test
-
Becton Dickinson (BDX) Announces Board of Directors for embecta, the Planned Spinoff of its Diabetes Care Business
-
BD Announces Board of Directors for embecta, the Planned Spinoff of its Diabetes Care Business
-
Becton Dickinson (BDX) Acquires Scanwell Health, Inc. to Expand and Scale Digital At-Home Testing
-
BD Acquires Scanwell Health, Inc. to Expand and Scale Digital At-Home Testing
-
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
-
Becton Dickinson (BDX) Acquires Tissuemed
-
BD Acquires Tissuemed, Ltd. To Add Advanced Sealant To Its Portfolio Of Surgical Solutions
-
BD Selects "embecta" as Name of New Company for Planned Spinoff of Diabetes Care Business; Announces Remainder of Leadership Team
-
Becton Dickinson (BDX) Acquires Venclose, Inc.
-
BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease
-
BD Issues 2021 Global Inclusion, Diversity and Equity Report
-
Becton Dickinson (BDX) Confident its COVID-19 Tests Capable of Detecting Omicron Variant
-
BD Statement on Testing for the COVID-19 Omicron Variant of Concern
-
BD Names Dr. Joseph M. Smith as Chief Scientific Officer
-
BD Names Francesca DeMartino as Senior Vice President of Investor Relations
-
Becton Dickinson (BDX) is targeting long-term compound annual revenue growth of 5.5%
-
BD to Highlight Progress Against BD 2025 Strategy and Plans for Long-Term Growth
-
BD Announces Fourth Fiscal Quarter And Full Year 2021 Results; Issues Fiscal Year 2022 Guidance
-
Becton Dickinson (BDX) Announces 10M Share Buyback; Declares $0.87 Dividend
-
BD Board Increases Dividend for 50th Consecutive Year, Authorizes 10 Million Additional Share Repurchases
-
Becton Dickinson (BDX) Announces Collaboration With US Govt for COVID-19 Combination Diagnostic Tests
-
BD Collaborates with U.S. Government on Development of COVID-19 Combination Diagnostic Tests
-
BD to Host Investor Day on November 12
-
Becton Dickinson (BDX) Begins Shipments of its Smartphone Interpreted OTC Rapid COVID-19 Test
-
BD Begins Shipments Of First Smartphone Interpreted Over-The-Counter Rapid COVID-19 Test
-
Becton Dickinson (BDX) Appoints Carrie Byington To its Board

